The development of a complex multicellular organism requires precisely regulated patterns of gene expression. Our long-term goal is to learn about these control mechanisms in the context of the AP-2 family of transcription factors, especially Tcfap2a. This gene may provide a link between the genetic and environmental origins of human birth defects. First, chromosomal mapping studies have implicated Tcfap2a as a potential candidate gene for human orofacial clefting. Second, Tcfap2a expression is responsive to the teratogen retinoic acid. These two observations are consistent with the pattern of Tcfap2a expression detected during vertebrate embryogenesis. Tcfap2a is expressed in many tissues undergoing complex morphogenetic changes, especially the neural crest, the face and the limb bud. Moreover, Tcfap2a is a vital component of the regulatory network directing normal vertebrate embryogenesis. Mice heterozygous for the Tcfap2a gene exhibit craniofacial defects including maxillary bending. Tcfap2a-null mice have severe developmental abnormalities: exencephaly and they lack a recognizable face. Detailed studies indicate that six basic developmental programs rely on Tcfap2a: formation of the neural tube, face, eyes, body-wall, heart, and limbs. Tcfap2a is a powerful regulator of craniofacial development. Therefore, to gain insight into the origin of human congenital malformations, especially CLIP, this proposal seeks to determine the regulatory hierarchy by which Tcfap2a controls craniofacial morphogenesis.
Three Specific Aims will be undertaken. First, the cis-acting sequences and trans-acting factors responsible for the expression of Tcfap2a in the face will be determined.
This aim will reveal the signal transduction pathways that are critical for the normal expression of Tcfap2a in the developing face. Second, since the role of Tcfap2a in craniofacial development is difficult to study in the null mouse (because multiple morphogenic processes shaping the head are disrupted), a novel strain of mouse will be generated in which Tcfap2a expression is removed only from the developing face. This new animal model will reveal the molecular and cellular mechanisms by which Tcfap2a specifically controls craniofacial formation. Third, the target genes through which Tcfap2a controls craniofacial morphogenesis will be identified. Together, these studies will provide valuable insight into both normal facial development and craniofacial malformations. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
2R01DE012728-07A1
Application #
6780116
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Small, Rochelle K
Project Start
1998-08-01
Project End
2009-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
7
Fiscal Year
2004
Total Cost
$423,780
Indirect Cost
Name
University of Colorado Denver
Department
Dentistry
Type
Schools of Dentistry
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Van Otterloo, Eric; Li, Hong; Jones, Kenneth L et al. (2018) AP-2? and AP-2? cooperatively orchestrate homeobox gene expression during branchial arch patterning. Development 145:
Hicks, Emily Anne; Zaveri, Mizna; Deschamps, Paula A et al. (2018) Conditional Deletion of AP-2? and AP-2? in the Developing Murine Retina Leads to Altered Amacrine Cell Mosaics and Disrupted Visual Function. Invest Ophthalmol Vis Sci 59:2229-2239
Leach, Sonia M; Feng, Weiguo; Williams, Trevor (2017) Gene expression profile data for mouse facial development. Data Brief 13:242-247
Hooper, Joan E; Feng, Weiguo; Li, Hong et al. (2017) Systems biology of facial development: contributions of ectoderm and mesenchyme. Dev Biol 426:97-114
Martino, Vanessa B; Sabljic, Thomas; Deschamps, Paula et al. (2016) Conditional deletion of AP-2? in mouse cranial neural crest results in anterior segment dysgenesis and early-onset glaucoma. Dis Model Mech 9:849-61
Chen, Lisheng; Martino, Vanessa; Dombkowski, Alan et al. (2016) AP-2? Is a Downstream Effector of PITX2 Required to Specify Endothelium and Establish Angiogenic Privilege During Corneal Development. Invest Ophthalmol Vis Sci 57:1072-81
Green, Rebecca M; Feng, Weiguo; Phang, Tzulip et al. (2015) Tfap2a-dependent changes in mouse facial morphology result in clefting that can be ameliorated by a reduction in Fgf8 gene dosage. Dis Model Mech 8:31-43
Hooper, Joan E (2014) A survey of software for genome-wide discovery of differential splicing in RNA-Seq data. Hum Genomics 8:3
Kurosaka, Hiroshi; Iulianella, Angelo; Williams, Trevor et al. (2014) Disrupting hedgehog and WNT signaling interactions promotes cleft lip pathogenesis. J Clin Invest 124:1660-71
Li, Hong; Williams, Trevor (2013) Separation of mouse embryonic facial ectoderm and mesenchyme. J Vis Exp :

Showing the most recent 10 out of 38 publications